International Immunology · 2002 · 14 citations · 36 references
Life SciencesImmunologyPathologyCellular ImmunologyImmunopathologyTransplant ImmunologyCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesGraft-versus-host DiseaseT Cell BiologyCd8 T Cell ActivationCytotoxic T Lymphocyte InfiltrationGraft-versus-host Disease PathophysiologyInflammatory Tissue DamageT Cell Activation CytokinesT Cell CytotoxicityT-cell Immune ResponsesTh1 Immune Response
Acute graft-versus-host disease (GvHD) is a serious complication after allogeneic bone marrow transplantation. Donor-derived T cells infiltrate recipient target organs and cause severe tissue damage, often leading to death of the affected patient. Tissue destruction is a direct result of donor CD8+ T cell activation and cell-mediated cytotoxicity. IL-18 is a novel pro-inflammatory cytokine with potent T(h)1 immune response-promoting and cytotoxic T lymphocyte (CTL)-inducing activity. IL-18 is strongly induced in experimental mouse models and human patients with acute GvHD. However, the precise role of IL-18 in the development of acute GvHD is still unknown. In this study, we have used IL-18-binding protein, a soluble IL-18 decoy receptor, to specifically neutralize IL-18 in vivo and in vitro. Our results demonstrate that IL-18 is induced during GvHD. However, its effect in the induction of GvHD appears to be redundant, since neutralization of IL-18 does not alter any disease parameter analyzed. Our study further shows that IFN-gamma production and CTL induction upon activation by T cell mitogens or by alloantigen does not involve IL-18-mediated amplification, in contrast to lipopolysaccharide-induced IFN-gamma production. We conclude that IL-18 expression correlates with the course of GvHD; however, its effect is dispensable for IFN-gamma and CTL induction for the initiation phase of this disease, most likely due to direct, IL-18-independent, CTL activation.
36
Thomas Brunner, R J Mogil, Drake LaFace et al. · Nature · 1995 · 1.3K citations · Full text
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Kiyoshi Takeda, Hiroko Tsutsui, Tomohiro Yoshimoto et al. · Immunity · 1998 · 914 citations · Full text
Interleukin-18 Binding Protein
Daniela Novick, Soo Hyun Kim, Giamila Fantuzzi et al. · Immunity · 1999 · 775 citations · Full text